• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Balancing health and safety: Cardiovascular medications during pregnancy and lactation.

作者信息

van der Bijl Marte F, Verdonk Koen, Roeters van Lennep Jeanine E

机构信息

Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

Case Rep Womens Health. 2024 Sep 4;43:e00648. doi: 10.1016/j.crwh.2024.e00648. eCollection 2024 Oct.

DOI:10.1016/j.crwh.2024.e00648
PMID:39474159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11519779/
Abstract
摘要

相似文献

1
Balancing health and safety: Cardiovascular medications during pregnancy and lactation.平衡健康与安全：孕期及哺乳期的心血管药物
Case Rep Womens Health. 2024 Sep 4;43:e00648. doi: 10.1016/j.crwh.2024.e00648. eCollection 2024 Oct.
2
Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.妊娠期和哺乳期皮肤病药物的安全性：第一部分。妊娠期。
J Am Acad Dermatol. 2014 Mar;70(3):401.e1-14; quiz 415. doi: 10.1016/j.jaad.2013.09.010.
3
Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy.妊娠和哺乳期皮肤病药物的安全性：最新进展——第 1 部分：妊娠。
J Am Acad Dermatol. 2024 Oct;91(4):619-648. doi: 10.1016/j.jaad.2023.10.072. Epub 2024 Jan 26.
4
The use of prescription medications and non-prescription medications during lactation in a prospective Canadian cohort study.在一项前瞻性加拿大队列研究中，哺乳期妇女使用处方药物和非处方药物的情况。
Int Breastfeed J. 2024 Apr 8;19(1):23. doi: 10.1186/s13006-024-00628-x.
5
Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.妊娠期和哺乳期的皮肤科药物安全性：第二部分。哺乳期。
J Am Acad Dermatol. 2014 Mar;70(3):417.e1-10; quiz 427. doi: 10.1016/j.jaad.2013.09.009.
6
Evaluation of Lactation Compatibility Reference Recommendations.哺乳兼容性参考推荐评估。
Ann Pharmacother. 2019 Sep;53(9):899-904. doi: 10.1177/1060028019839389. Epub 2019 Mar 24.
7
Safety of dermatologic medications in pregnancy and lactation: An update-Part II: Lactation.妊娠期和哺乳期皮肤病药物的安全性：更新部分 II：哺乳期。
J Am Acad Dermatol. 2024 Oct;91(4):651-668. doi: 10.1016/j.jaad.2023.10.071. Epub 2024 Jan 26.
8
Cardiovascular Medications in Pregnancy: A Primer.妊娠期心血管药物：概述。
Cardiol Clin. 2021 Feb;39(1):33-54. doi: 10.1016/j.ccl.2020.09.011. Epub 2020 Nov 2.
9
Extent of medication use in breastfeeding women.哺乳期女性用药情况
Breastfeed Med. 2007 Sep;2(3):145-51. doi: 10.1089/bfm.2007.0010.
10
Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current Practice.孕期及哺乳期用药选择指南：药剂师当前实践所需了解的内容。
Ann Pharmacother. 2018 Aug;52(8):810-818. doi: 10.1177/1060028018764447. Epub 2018 Mar 9.

本文引用的文献

1
Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC).患有心脏病的女性在子宫内接触β受体阻滞剂后的围产期结局：ESC EORP 妊娠和心脏疾病登记处（ROPAC）的数据。
Int J Cardiol. 2024 Sep 1;410:132234. doi: 10.1016/j.ijcard.2024.132234. Epub 2024 Jun 4.
2
Protection by inclusion: Increasing enrollment of women in cardiovascular trials.纳入带来的保护：增加女性参与心血管试验的人数。
Am Heart J Plus. 2022 Jan 31;13:100091. doi: 10.1016/j.ahjo.2022.100091. eCollection 2022 Jan.
3
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
4
Pregnant and lactating women should be included in clinical trials for cardiovascular disease.孕妇和哺乳期妇女应纳入心血管疾病的临床试验。
Nat Med. 2023 Aug;29(8):1897-1899. doi: 10.1038/s41591-023-02416-2.
5
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.阿司匹林在心血管疾病中的剂量比较效果。
N Engl J Med. 2021 May 27;384(21):1981-1990. doi: 10.1056/NEJMoa2102137. Epub 2021 May 15.
6
Antiplatelet therapy in pregnancy: A systematic review.妊娠期抗血小板治疗：系统评价。
Pharmacol Res. 2021 Jun;168:105547. doi: 10.1016/j.phrs.2021.105547. Epub 2021 Mar 12.
7
Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care.妊娠期用药：影响临床治疗的药物作用及生理变化。
Semin Perinatol. 2020 Apr;44(3):151221. doi: 10.1016/j.semperi.2020.151221. Epub 2020 Jan 25.
8
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
9
Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review.妊娠期心血管疾病药物治疗：JACC 现状评论。
J Am Coll Cardiol. 2019 Feb 5;73(4):457-476. doi: 10.1016/j.jacc.2018.10.075.
10
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.2018年欧洲心脏病学会妊娠期心血管疾病管理指南。
Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.